Table 5.
Results of treatment comparisons for postoperative 24 h.
| A | N = 1;0.00 (−0.62; 0.62) | |||||||||
| 0.45 (0.04;5.05) | B | N = 1;0.05 (−0.46; 0.56) | ||||||||
| 0.52 (0.11;2.51) | 1.16 (0.18;7.33) | C | N = 1;0.00 (−0.88; 0.88) | N = 3;−0.39 (−0.71; −0.08) | N = 1;−0.79 (−1.41; −0.17) | |||||
| 1.29 (0.18;9.26) | 2.87 (0.20;40.92) | 2.47 (0.36;16.78) | D | N = 1;0.13 (−0.49; 0.75) | ||||||
| 1.00 (0.31;3.20) | 2.24 (0.27;18.73) | 1.92 (0.67;5.56) | 0.78 (0.16;3.84) | E | N = 2;−0.08 (−1.20; 1.05) | N = 3;−0.94 (−1.49; −0.39) | ||||
| 1.23 (0.27;5.68) | 2.74 (0.26;28.49) | 2.36 (0.56;10.00) | 0.96 (0.15;6.26) | 1.23 (0.45;3.32) | F | |||||
| 5.42 (0.51;58.14) | 12.09 (0.81;181.01) | 10.41 (1.43;75.58) | 4.21 (0.31;57.43) | 5.41 (0.68;42.83) | 4.41 (0.45;43.54) | G | N = 1;−1.34(−1.97;−0.71) | |||
| 0.30 (0.08;1.23) | 0.68 (0.09;5.01) | 0.58 (0.27;1.27) | 0.24 (0.04;1.40) | 0.30 (0.14;0.66) | 0.25 (0.07;0.87) | 0.06 (0.01;0.38) | H | N = 1;0.58 (−0.06; 1.21) | N = 1;−0.21 (−0.92; 0.51) | |
| 0.11 (0.01;0.87) | 0.24 (0.02;3.00) | 0.21 (0.04;1.16) | 0.08 (0.01;0.88) | 0.11 (0.02;0.61) | 0.09 (0.01;0.64) | 0.02 (0.00;0.23) | 0.36 (0.08;1.65) | I | ||
| 0.54 (0.08;3.60) | 1.21 (0.12;12.04) | 1.04 (0.27;4.11) | 0.42 (0.05;3.75) | 0.54 (0.12;2.41) | 0.44 (0.07;2.64) | 0.10 (0.02;0.42) | 1.79 (0.50;6.40) | 5.00 (0.68;36.72) | J | N = 1;−0.81 (−1.44; −0.18) |
| 2.59 (0.35;19.48) | 5.79 (0.56;59.49) | 4.98 (1.19;20.77) | 2.02 (0.20;19.98) | 2.59 (0.50;13.46) | 2.11 (0.31;14.32) | 0.48 (0.07;3.21) | 8.52 (1.98;36.69) | 23.86 (2.88;197.92) | 4.77 (1.36;16.69) | K |
1. Lower–left triangle presents the findings (MD with 95%CI) of the network meta–analysis conducted using Stata 15.1. Upper–right triangle presents the findings (SMD with 95% CI) of the pair–wise meta–analyses conducted using STATA 15.1 and N refers to the numbers of RCTs which compared the 2 interventions directly. 3. A positive MD favors the lower–right intervention; a negative MD favors the upper–left intervention.4. Statistically significant findings are shaded. A, ANB (axillary nerve block); B, CEB (cervical epidural block); C, EA (external application); D, HTESPB (high thoracic erector spinae plane block); E, IAI (intra–articular injection); F, ICSCB (infraclavicular–suprascapular blocks); G, INB (interscalene nerve block); H, INB+IAI (interscalene nerve block + intra–articular injection); I, INB+IVA (interscalene nerve block + intravenous administration); J, INB+OA (interscalene nerve block + oral administration); K, INB+SSNB (interscalene nerve block + suprascapular nerve block); L, OA (oral administration); M, PL (placebo); N, SCNB (supraclavicular nerve block); O= SGB (stellate ganglion block); P, SSNB (suprascapular nerve block); Q, SSNB+ANB (suprascapular nerve block + axillary nerve block).
Red represents the code of intervention measures and green represents the significant difference between two intervention measures with statistical significance.